Antithrombotic Therapy Following CABG: For the Patient, Not the Bypass Graft.
Publication
, Journal Article
Alexander, JH
Published in: J Am Coll Cardiol
January 22, 2019
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Am Coll Cardiol
DOI
EISSN
1558-3597
Publication Date
January 22, 2019
Volume
73
Issue
2
Start / End Page
131 / 133
Location
United States
Related Subject Headings
- Rivaroxaban
- Humans
- Graft Occlusion, Vascular
- Fibrinolytic Agents
- Coronary Artery Bypass
- Cardiovascular System & Hematology
- Aspirin
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Alexander, J. H. (2019). Antithrombotic Therapy Following CABG: For the Patient, Not the Bypass Graft. J Am Coll Cardiol, 73(2), 131–133. https://doi.org/10.1016/j.jacc.2018.10.049
Alexander, John H. “Antithrombotic Therapy Following CABG: For the Patient, Not the Bypass Graft.” J Am Coll Cardiol 73, no. 2 (January 22, 2019): 131–33. https://doi.org/10.1016/j.jacc.2018.10.049.
Alexander JH. Antithrombotic Therapy Following CABG: For the Patient, Not the Bypass Graft. J Am Coll Cardiol. 2019 Jan 22;73(2):131–3.
Alexander, John H. “Antithrombotic Therapy Following CABG: For the Patient, Not the Bypass Graft.” J Am Coll Cardiol, vol. 73, no. 2, Jan. 2019, pp. 131–33. Pubmed, doi:10.1016/j.jacc.2018.10.049.
Alexander JH. Antithrombotic Therapy Following CABG: For the Patient, Not the Bypass Graft. J Am Coll Cardiol. 2019 Jan 22;73(2):131–133.
Published In
J Am Coll Cardiol
DOI
EISSN
1558-3597
Publication Date
January 22, 2019
Volume
73
Issue
2
Start / End Page
131 / 133
Location
United States
Related Subject Headings
- Rivaroxaban
- Humans
- Graft Occlusion, Vascular
- Fibrinolytic Agents
- Coronary Artery Bypass
- Cardiovascular System & Hematology
- Aspirin
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology